Macalisang, Jerlyn .
HRN: 23-71-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2023
CEFUROXIME 1.5GM (VIAL)
09/15/2023
09/21/2023
IV
1 Vial
Q8H
S/p LTCS W/ BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes